Сравнение

Petrelintide vs. Pramlintid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Метаболизм

Номер CAS

нет данных

151126-32-8

Молекулярная масса

нет данных

3949.4 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Petrelintide

As an amylin analogue, petrelintide acts through amylin receptors, promoting satiety and slowed gastric emptying — a satiety pathway independent of the GLP-1 axis.

Pramlintid

Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Petrelintide	Pramlintid
Германия	Не одобрено	Не одобрено
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Petrelintide and Pramlintid?: Petrelintide is classified as "Метаболизм", while Pramlintid is classified as "Метаболизм". Petrelintide: Petrelintide is a long-acting amylin analogue (Zealand Pharma, with Roche) for once-weekly subcutaneous use — developed for weight management with a focus on strong tolerability. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Petrelintide or Pramlintid?: The highest available evidence level is "РКИ на людях" for Petrelintide and "РКИ на людях" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Petrelintide and Pramlintid in Germany and the United States?: Германия: Petrelintide — Не одобрено, Pramlintid — Не одобрено. США: Petrelintide — Не одобрено, Pramlintid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Petrelintide

Pramlintid

Германия

Не одобрено

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Petrelintide and Pramlintid?

Petrelintide is classified as "Метаболизм", while Pramlintid is classified as "Метаболизм". Petrelintide: Petrelintide is a long-acting amylin analogue (Zealand Pharma, with Roche) for once-weekly subcutaneous use — developed for weight management with a focus on strong tolerability. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Petrelintide or Pramlintid?

The highest available evidence level is "РКИ на людях" for Petrelintide and "РКИ на людях" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Petrelintide and Pramlintid in Germany and the United States?

Германия: Petrelintide — Не одобрено, Pramlintid — Не одобрено. США: Petrelintide — Не одобрено, Pramlintid — Рецептурный. These are factual summaries with source and review date on the individual pages.